Module 2 - Anti-inflammatory and Anti-pyretic Drugs Flashcards
Anti-inflammatory
reduces inflammation
Anti-pyretic
reduces temperature
NSAIDS examples
voltaren, aspirin (causes bleeding), advil/ motrin, naprosyn, celebrex
NSAID Classification
1) Acetic Acid Derivatives
2) Carboxylic Acid
3) COX-2 Inhibitors
4) Fenamates
5) Napthylalkanones
6) Oxicams
7) Propionic
NSAID:
Mechanism of Action
1) Inhibit COX-1 and COX2 enzymes
- released from injured tissue
- A few drugs selectively inhibit COX-2
2) COX-1 enzymes lead to physiologic prostaglandin production
3) COX-2 lead to pathologic prostaglandin production
**analgesic, anti-inflammatory and antipyretic properties
where do prostaglandins come from?
released from injurred tissue
common uses of NSAIDS
Mild to moderate pain Fever Rheumatoid arthritis (RA) pain Osteoarthritis (OA) pain Primary dysmenorrhea Acute gout Bursitis Tendinitis
diclofenac (Voltaren)
oral: inflammatory disorders
topical: osteoarthritis
indomethacin (Indocid)
-Used to treat inflammatory disorders, such as ankylosing, spondylitis, arthritis, acute gout attacks
Gout
a form of arthritis marked by the deposition of monosodium urate crystals in joints and other tissues.(usually starts in knee or metatarsalphalangeal joints)
Symptoms: moderate pain which increases in intensity; also possibly low-grade fever and joint inflammation (hot, tender, dusky-red or cyanotic joints).
ketorolac (Toradol)
short term pain management (
Propionic Acid Derivatives Examples
Ibuprofen
Naproxen
Propionic Acid Derivatives Uses
- mild-moderate pain
- Work well for menstrual cramps
COX-2 Inhibitors
- inhibit cyclooxygenase-2 enzymes which are involved in inflammatory processes
- osteoarthritis and rheumatoid arthritis (bone pain)
- Prescription only
- good because do not inhibit COX-1: which would block the prostaglandins responsible for maintaining an intact gastrointestinal mucosa
acetylsalicylic acid (ASA) – (Aspirin)
- mild-moderate pain and fever in adults
- Should never be used for fever with children due to increased risk of Reye’s syndrome
- 81 mg daily or 325 mg daily in an enteric coated form